![Margaret Alexander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 168 578 $ in data 31/05/2026
Margaret Alexander is President, Chief Executive Officer & Director at Ovid Therapeutics, Inc. since 2026.
Formerly, Ms. Alexander was Managing Director-Reputation & Risk Management at Syneos Health, Inc. from 2015 to 2020.
Ms. Alexander completed undergraduate studies at The College of William & Mary.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2026 | 61.750 ( 0,03% ) | 168 578 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| OVID THERAPEUTICS INC. | Amministratore Delegato | 01/01/2026 |
| Società | Posizione | Fine |
|---|---|---|
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | 01/06/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Provides outsourced clinical development and commercialization services to biopharmaceutical companies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
